Global Health share price
NSE: MEDANTABSE: 543654Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,198.20.
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹31,862 Cr262nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 57.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 8.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 15.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 14.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.30
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,57,71864.6% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 30 Jul
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,304 Crup 12.51%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹157 Crup 11.01%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 12.1%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 14 Nov | Dec 2024Filed 4 Feb | Mar 2025Filed 10 Jun | Jun 2025Filed 7 Aug | Sep 2025Filed 7 Nov | Dec 2025Filed 4 Feb | Mar 2026Filed 14 May | Jun 2026Filed 30 Jul |
|---|---|---|---|---|---|---|---|---|
| Revenue | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | 1,304 |
| Net profit | 131 | 143 | 101 | 159 | 158 | 95 | 142 | 157 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 13.7% | 15.1% | 10.9% | 15.4% | 14.4% | 8.5% | 12.2% | 12.1% |
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare services, which carries all its revenue.
Valuation
Today, against the company's own history.PE ratio and valuation history
At or below today's level on 13% of 724 trading days since Nov 2023.
At or below today's level on 5% of 744 trading days over the last 3 years.
At or below today's level on 8% of 724 trading days since Nov 2023.
At or below today's level on 90% of 976 trading days since Nov 2022.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −19.7% | +15.6% | −30.6% | 0.1% |
| 3 years | +22.2% | +19.4% | +2.3% | 0.0% |
Mutual funds holding it
149 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 64 of the 95 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 3 more funds filed their first portfolio on record, holding it.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 4
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 2
- AddedAdded. Funds that held more shares than at the end of the month before.
- 74
- CutCut. Funds that held fewer shares than at the end of the month before.
- 21
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 45
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 4
| Fund | |||
|---|---|---|---|
 Kotak Mid Cap FundKotak Mahindra Mutual Fund | 88,83,314 | 1.82% | ₹1,212.6 Cr |
 Invesco India Mid Cap FundInvesco Mutual Fund | 45,77,395 | 3.97% | ₹624.8 Cr |
 UTI Flexi Cap FundUTI Mutual Fund | 32,87,867 | 2.00% | ₹448.8 Cr |
| Invesco India Small Cap FundInvesco Mutual Fund | 21,94,163 | 1.86% | ₹299.5 Cr |
| Invesco India Contra FundInvesco Mutual Fund | 21,02,004 | 1.49% | ₹286.9 Cr |
| Invesco India Focused FundInvesco Mutual Fund | 17,12,376 | 3.75% | ₹233.7 Cr |
| Invesco India Large & Mid Cap FundInvesco Mutual Fund | 17,04,265 | 1.91% | ₹232.6 Cr |
 Canara Robeco Small Cap FundCanara Robeco Mutual Fund | 17,01,593 | 1.66% | ₹232.3 Cr |
| Canara Robeco Large and Mid Cap FundCanara Robeco Mutual Fund | 15,22,049 | 0.85% | ₹207.8 Cr |
 HDFC Multi Cap FundHDFC Mutual Fund | 11,25,000 | 0.79% | ₹153.6 Cr |
Peers and competitors
Hospital, 38 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Global Health in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Max Healthcare InstituteMAXHEALTH | 79,325 | 54.4 | 7.4 | 35.4 | +16.0% | +27.0% | 14.5% | 13.0% | 0.25% |
 Aster DM Quality CareASTERDM | 56,201 | 176.4 | – | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.47% |
 Fortis HealthcareFORTIS | 53,821 | 51.4 | 5.4 | 26.3 | +17.5% | +20.7% | 11.1% | 12.7% | 0.14% |
 Narayana HrudayalayaNH | 33,656 | 41.2 | 7.4 | 20.8 | +57.8% | +3.9% | 20.0% | 13.1% | 0.27% |
 Krishna Institute of Medical SciencesKIMS | 27,937 | 136.6 | 12.4 | 37.4 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,024 | 101.3 | 7.4 | 24.6 | – | – | 7.6% | 14.1% | 0.00% |
 Rainbow Childrens MedicareRAINBOW | 11,879 | 41.6 | 7.2 | 20.6 | +18.3% | +10.9% | 18.3% | 25.0% | 0.30% |
 Park Medi WorldPARKHOSPS | 9,291 | – | 4.6 | – | – | – | – | – | 0.00% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.| Ex-date | Type | Per share |
|---|---|---|
| 14 Aug 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.50 |
| 22 Aug 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.50 |
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
23 Oct · Disclosure
Sep 2026
28 Sep · General Updates
22 Sep · Analysts
Global Health share price by year
Each calendar year to 2025.Global Health share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,186.40 | +10.0% | 1,427.20 | 1,001.60 |
| 2024 | 1,078.50 | +12.4% | 1,487.05 | 944.55 |
| 2023 | 959.15 | +104.6% | 1,003.50 | 430.40 |
| 2022 | 468.80 | – | 471.30 | 414.15 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 1,192.00 | 1,201.10 | 1,165.00 | 1,185.00 | 1,174.81 | 2,57,718 | 64.6% |
| 22 Oct 2026 | 1,231.90 | 1,231.90 | 1,192.10 | 1,198.20 | 1,206.14 | 5,24,295 | 82.7% |
| 21 Oct 2026 | 1,244.00 | 1,244.00 | 1,213.10 | 1,232.40 | 1,226.12 | 1,39,297 | 58.1% |
| 19 Oct 2026 | 1,240.80 | 1,252.60 | 1,230.00 | 1,238.10 | 1,242.17 | 1,14,325 | 59.0% |
| 16 Oct 2026 | 1,281.00 | 1,290.80 | 1,230.50 | 1,240.00 | 1,259.71 | 3,02,997 | 69.3% |
| 15 Oct 2026 | 1,286.40 | 1,303.20 | 1,267.30 | 1,275.50 | 1,289.96 | 1,51,058 | 49.0% |
| 14 Oct 2026 | 1,286.00 | 1,287.70 | 1,257.50 | 1,280.00 | 1,272.08 | 1,19,827 | 49.6% |
| 13 Oct 2026 | 1,309.40 | 1,318.10 | 1,276.00 | 1,280.20 | 1,284.09 | 75,161 | 50.5% |
| 12 Oct 2026 | 1,311.90 | 1,322.10 | 1,298.70 | 1,309.40 | 1,309.52 | 1,09,033 | 41.6% |
| 9 Oct 2026 | 1,290.00 | 1,322.60 | 1,288.80 | 1,312.70 | 1,308.94 | 2,35,514 | 46.3% |
About Global Health
Global Health Limited, which trades as Medanta, is a multi-specialty tertiary and quaternary healthcare provider in India. It runs large hospitals that offer care across more than 30 specialties, and its model of care is doctor-led. The company was founded by Dr. Naresh Trehan. The hospitals were designed by Canadian architects and have dedicated specialty floors. Patients from more than 130 countries have come to it for treatment.
Medanta operates six hospitals in six cities: Gurugram, Lucknow, Patna, Ranchi, Indore and Noida. The network had 3,737 installed beds at 30 June 2026. The Gurugram hospital, Medanta The Medicity, is the flagship, and the corporate office is on that campus in Sector 38. The hospitals are in Haryana, Uttar Pradesh, Bihar, Jharkhand and Madhya Pradesh, and the network has more than 950 ICU beds and more than 100 operating theatres.
Outside the hospitals, the company runs Medanta Clinics, Medanta Labs for diagnostic testing, and pharmacies, with 9 clinics, 12 labs and 22 pharmacies. Its services also include telemedicine, Tele-ICU services and home healthcare.
Global Health Limited was incorporated in 2004. It grew from a single flagship hospital in Gurugram into a network of six hospitals. Carlyle Group and Temasek each bought a minority stake in the company. Its shares are listed on the BSE and the NSE, and Carlyle exited completely in the initial public offering. The registered office is in New Delhi.
- Legal name
- Global Health Limited
- NSE symbol
- MEDANTA
- BSE code
- 543654
- ISIN
- INE474Q01031
- Industry
- Healthcare Services
- Listed
- Nov 2022
- Face value
- ₹2
- CIN
- L85110DL2004PLC128319
- Corporate identity number, the registrar of companies' code for it